Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 7Spondylitis, Ankylosing 2Psoriasis 2Colitis, Ulcerative 2Sarcoidosis 1Plaque Psoriasis 1Nephrotic Syndrome 1Nephrosis, Lipoid 1Mucopolysaccharidosis VI 1Mucopolysaccharidosis II 1Mucopolysaccharidosis I 1Mucopolysaccharidoses 1Macular dystrophy, corneal type 1 1Kidney Diseases 1Inflammation 1Hidradenitis Suppurativa 1Glomerulosclerosis, Focal Segmental 1Dupuytren Contracture 1Crohn Disease 1Arthritis, Psoriatic 1Acne Vulgaris 1Abscess 1

Interventions

Adalimumab 2tocilizumab 1Vaccines 1Saline Solution 1Herpes Zoster Vaccine 1Etanercept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Spondylitis, Ankylosing × Adalimumab × Clear all
NCT01060098 2020-01-18

T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade

Imperial College London

Completed
48 enrolled 6 charts

Arthritis, Rheumatoid, Spondylitis, Ankylosing, Arthritis, Psoriatic

NCT00085644 2011-04-21

ATLAS

Abbott

Phase 3 Completed
315 enrolled 45 charts

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡